Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder
This study explores the application of the “dual control model” (DCM) in developing personalized treatments for hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD). The DCM posits that sexual response is governed by the balance between excitation and inhibition, suggesting that individualized pharmacological interventions could improve therapeutic